http://purl.org/np/RAmfHrKbv0W-nm3RoZQXip3qj4znm2UDUmTf6FHcPYqDw#Head http://purl.org/np/RAmfHrKbv0W-nm3RoZQXip3qj4znm2UDUmTf6FHcPYqDw http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAmfHrKbv0W-nm3RoZQXip3qj4znm2UDUmTf6FHcPYqDw#assertion http://purl.org/np/RAmfHrKbv0W-nm3RoZQXip3qj4znm2UDUmTf6FHcPYqDw http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAmfHrKbv0W-nm3RoZQXip3qj4znm2UDUmTf6FHcPYqDw#provenance http://purl.org/np/RAmfHrKbv0W-nm3RoZQXip3qj4znm2UDUmTf6FHcPYqDw http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAmfHrKbv0W-nm3RoZQXip3qj4znm2UDUmTf6FHcPYqDw#pubinfo http://purl.org/np/RAmfHrKbv0W-nm3RoZQXip3qj4znm2UDUmTf6FHcPYqDw http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAmfHrKbv0W-nm3RoZQXip3qj4znm2UDUmTf6FHcPYqDw#assertion http://purl.obolibrary.org/obo/DOID_8577 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAmfHrKbv0W-nm3RoZQXip3qj4znm2UDUmTf6FHcPYqDw#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_8577 http://purl.org/np/RAmfHrKbv0W-nm3RoZQXip3qj4znm2UDUmTf6FHcPYqDw#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAmfHrKbv0W-nm3RoZQXip3qj4znm2UDUmTf6FHcPYqDw#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB01190 http://purl.org/np/RAmfHrKbv0W-nm3RoZQXip3qj4znm2UDUmTf6FHcPYqDw#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAmfHrKbv0W-nm3RoZQXip3qj4znm2UDUmTf6FHcPYqDw#association http://www.w3.org/2000/01/rdf-schema#label "Clindamycin Phosphate Foam, 1% is contraindicated in individuals with a history of regional enteritis or ulcerative colitis, or a history of antibiotic-associated colitis (including pseudomembranous colitis). Clindamycin Phosphate Foam, 1% is contraindicated in individuals with a history of regional enteritis or ulcerative colitis, or a history of antibiotic-associated colitis, (including pseudomembranous colitis). ( 4" http://purl.org/np/RAmfHrKbv0W-nm3RoZQXip3qj4znm2UDUmTf6FHcPYqDw#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAmfHrKbv0W-nm3RoZQXip3qj4znm2UDUmTf6FHcPYqDw#association https://w3id.org/biolink/vocab/relation https://schema.org/MedicalContraindication https://identifiers.org/drugbank:DB01190 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAmfHrKbv0W-nm3RoZQXip3qj4znm2UDUmTf6FHcPYqDw#provenance http://purl.org/np/RAmfHrKbv0W-nm3RoZQXip3qj4znm2UDUmTf6FHcPYqDw#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAmfHrKbv0W-nm3RoZQXip3qj4znm2UDUmTf6FHcPYqDw#pubinfo http://purl.org/np/RAmfHrKbv0W-nm3RoZQXip3qj4znm2UDUmTf6FHcPYqDw#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAmfHrKbv0W-nm3RoZQXip3qj4znm2UDUmTf6FHcPYqDw#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAmfHrKbv0W-nm3RoZQXip3qj4znm2UDUmTf6FHcPYqDw#sig http://purl.org/nanopub/x/hasSignature bGck+04u2LP+0tN3qXaGmBhjqVOXxEdsXD5xV7E+NwodRO2/ZAK/l6DRfgHypF9YKuYXGQ1vL38c30Xx03VKPJGJtEduYJfFvhWMVcXiBHDZiYyUZB5sQTT30tFAugQXWxupPmFpae8N8In3h4jyU6CN3CvAi0sx83ezXqIbM3U= http://purl.org/np/RAmfHrKbv0W-nm3RoZQXip3qj4znm2UDUmTf6FHcPYqDw#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAmfHrKbv0W-nm3RoZQXip3qj4znm2UDUmTf6FHcPYqDw http://purl.org/np/RAmfHrKbv0W-nm3RoZQXip3qj4znm2UDUmTf6FHcPYqDw http://purl.org/dc/terms/created 2021-08-23T12:22:08.385+02:00 http://purl.org/np/RAmfHrKbv0W-nm3RoZQXip3qj4znm2UDUmTf6FHcPYqDw http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAmfHrKbv0W-nm3RoZQXip3qj4znm2UDUmTf6FHcPYqDw https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAmfHrKbv0W-nm3RoZQXip3qj4znm2UDUmTf6FHcPYqDw https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAmfHrKbv0W-nm3RoZQXip3qj4znm2UDUmTf6FHcPYqDw https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY